AMORCHEM
AmorChem l.p., our fourth focused fund, was launched in 2011 to increase the commercial potential of the quality academic research carried out in Quebec. AmorChem is focused on investing in promising life science projects originating from Québec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept in a semi-virtual mode. AmorChem will generate returns through a two-pronged exit strategy:
AMORCHEM
Industry:
Venture Capital
Founded:
2011-01-01
Status:
Active
Contact:
514-283-3602
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Apache Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Elevate Ventures
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
GV
Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward.
Headline
Headline is a global venture capital firm investing in winning teams across stages and geographies.
Oregon Venture Fund
Oregon Venture Fund is a venture capital fund that provides funding and support to build the next generation of growth companies.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Soma Capital
Soma Capital is venture capital fund that focuses on investing in software to automate the world across all sectors and geographies.
Current Employees Featured
Founder
Investors List
Venture Capital Catalyst Initiative (VCCI)
Venture Capital Catalyst Initiative (VCCI) investment in Grant - Amorchem
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-21 | Giiant Pharma | Amorchem investment in Seed Round - Giiant Pharma | 15 M CAD |
| 2020-09-08 | Inversago Pharma | Amorchem investment in Series B - Inversago Pharma | 35 M USD |
| 2018-07-25 | Inversago Pharma | Amorchem investment in Series A - Inversago Pharma | 7 M USD |
| 2018-03-26 | Semathera | Amorchem investment in Venture Round - Semathera | 2.6 M USD |
| 2017-09-11 | SpecificiT Pharma | Amorchem investment in Seed Round - SpecificiT Pharma | N/A |